Gauss

Recombinant Human CD19-Fc Chimera (carrier-free) 100 µg

Réf. UGAP : 3689519 Réf. Fournisseur : 789006 Réf. Constructeur : 789006
Recombinant Human CD19-Fc Chimera (carrier-free) 100 µg
Recombinant Human CD19-Fc Chimera (carrier-free) 100 µg
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.
Il ne reste que 0 exemplaires.

Points clés

CD19 is a 95 kD transmembrane glycoprotein that functions as a co-receptor for the B-cell antigen receptor (BCR) complex on B lymphocytes. CD19 is expressed throughout B cell development, and it is commonly used as a B-cell lineage marker. CD19 plays an important role in B-cell activation and humoral immune responses. It is required for the responsiveness of mature B cells to antigen stimulation, germinal center development, and antibody affinity maturation. CD19's association with the BCR, CD81, CD38, CD21, CD22, and IFITM1/CD225/Leu13 enables CD19 to amplify B-cell signaling and decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens. CD19 activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca2+ stores. CD19 polymorphisms are associated with the development of autoimmunity by promoting autoantibody production. Homozygous mutations in CD19 cause a type of hypogammaglobulinemia in which the response of mature B cells to antigenic stimulation is defective.;

En savoir plus

Garantie

Garantie 0 Mois

Description

CD19 is a 95 kD transmembrane glycoprotein that functions as a co-receptor for the B-cell antigen receptor (BCR) complex on B lymphocytes. CD19 is expressed throughout B cell development, and it is commonly used as a B-cell lineage marker. CD19 plays an important role in B-cell activation and humoral immune responses. It is required for the responsiveness of mature B cells to antigen stimulation, germinal center development, and antibody affinity maturation. CD19's association with the BCR, CD81, CD38, CD21, CD22, and IFITM1/CD225/Leu13 enables CD19 to amplify B-cell signaling and decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens. CD19 activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca2+ stores. CD19 polymorphisms are associated with the development of autoimmunity by promoting autoantibody production. Homozygous mutations in CD19 cause a type of hypogammaglobulinemia in which the response of mature B cells to antigenic stimulation is defective.;

Caractéristiques

Fournisseur
BioLegend Europe BV
Marque
BIOLEGEND
Référence fabricant
789006
Référence distributeur
789006
Vendu par
100 μg
Quantité
N/A
Lieu de fabrication
USA
Lieu de stockage
Pays-Bas ou USA
Soumis à carboglace
non
Classement dans le catalogue fournisseur
Recombinant Protein
Certification
RUO
Type d’application
bioassay
Type de produit
Recombinant Protein
Température de conservation (°C)
-20 ou -70 °C
Température de transport
Blue Ice
Organisme cible
Human
Source biologique
CHO cells
Seuil de coupure des masses moléculaires MWCO
The 515 amino acid recombinant protein has a predicted molecular mass of approximately 57.5 kD. The DTT-reduced protein migrates at approximately 75 kD and the non-reduced protein migrate at approximately 150 kD by SDS-PAGE. Da
Concentration
10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration, please enter the lot number in our online tools.
Pureté
>95%, as determined by Coomassie stained SDS-PAGE. %
Matière dangereuse
Non
Code douanier
38220000
Classement NCBI
930
Nomenclature Nacres
NA.77
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA77
Nomenclature CNRS
NA77
Nomenclature CHU
18.551
Nomenclature DGOS
LD11AOOO
Reprise en cas d’erreur client
non